@nathandenbroeder.bsky.social
Proud to see our study on routine lab monitoring mentioned at ACR year in review!
🆕 Clinical Year in Review at #ACR25
By Dr. Bryant England @unmc.bsky.social
🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?
#RheumSky #MedSky #YearInReview
By Dr. Bryant England @unmc.bsky.social
🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?
#RheumSky #MedSky #YearInReview
November 5, 2025 at 1:18 PM
Proud to see our study on routine lab monitoring mentioned at ACR year in review!
Reposted
We wrote an article explaining why you shouldn't put several variables into a regression model and report which are statistically significant - even as exploratory research. bmjmedicine.bmj.com/content/4/1/.... How did we do?
October 27, 2025 at 5:39 PM
We wrote an article explaining why you shouldn't put several variables into a regression model and report which are statistically significant - even as exploratory research. bmjmedicine.bmj.com/content/4/1/.... How did we do?
Our paper on lab monitoring during DMARD use is published in Annals of Internal Medicine today! doi.org/10.7326/ANNA...
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
August 26, 2025 at 11:18 AM
Our paper on lab monitoring during DMARD use is published in Annals of Internal Medicine today! doi.org/10.7326/ANNA...
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
With n=4774 patients, 18383 patient-years and almost 60k lab sets, we found that very abnormal results are rare and associated with indicators of overtesting. #rheumatology
Reposted
NEW RESEARCH—Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial bit.ly/3GJHgDv #Medsky #Rheumsky
July 25, 2025 at 9:28 AM
NEW RESEARCH—Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial bit.ly/3GJHgDv #Medsky #Rheumsky